Jeff Sternlicht: Lifetime Exposure to LDL and Cardiovascular Risk
Jeff Sternlicht, Emergency Physician and Medical Director at Vituity, shared a post on LinkedIn:
“We May Be Starting Statins Too Late
What if we are not under-treating cholesterol…
But simply treating it too late?
We wait for thresholds.
We wait for scores.
We wait for patients to ‘qualify.’
But biologically, that may already be late.
Atherosclerosis does not begin at age 55.
It begins decades earlier.
Fatty streaks form in the 20s and 30s.
Plaque builds slowly over time.
And the artery keeps a record of every year of exposure.
Recent AHA, ACC, and NLA guidance is moving in one direction:
- earlier LDL lowering, not later.
Because cardiovascular risk is not just about how high LDL is today.
It is about how long the arteries have been exposed to it.
By the time someone meets traditional treatment thresholds, they may already have decades of cumulative ApoB exposure.
At that point, we’re not preventing disease.
We’re managing the consequences of it.
Lowering LDL later stabilizes plaque.
Lowering it earlier prevents it.
Those are two very different strategies.
The shift is already happening:
- from reacting to risk – to reducing lifetime exposure.
This is where preventive cardiometabolic care is going.
And it’s where I spend most of my time now.
Disclaimer: Views are my own and not those of my employer or affiliates.
For educational purposes only and not medical advice.”
Stay updated with Hemostasis Today.
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy